LINEAGE CELL THERAPEUTICS IN (LCTX)

US53566P1093 - Common Stock

0.58  +0.05 (+8.98%)

After market: 0.5655 -0.01 (-2.5%)

News Image
5 days ago - Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics Issues Letter to Stockholders

News Image
5 months ago - InvestorPlace

LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q2 2024

LCTX stock results show that Lineage Cell Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

News Image
8 months ago - Lineage Cell Therapeutics, Inc.

Lineage to Present at 2024 BIO International Convention

News Image
8 months ago - InvestorPlace

LCTX Stock Earnings: Lineage Cell Therapeutics Meets EPS, Beats Revenue for Q1 2024

LCTX stock results show that Lineage Cell Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

News Image
9 months ago - Lineage Cell Therapeutics, Inc.

Lineage Announces Changes to Board of Directors

News Image
10 months ago - InvestorPlace

LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q4 2023

LCTX stock results show that Lineage Cell Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

News Image
a year ago - Market News Video

Friday 2/9 Insider Buying Report: BRTX, LCTX